RAAS Inhibitor Drugs in Dialysis Patients

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 350 participants.

Also called NCT01635387

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 350 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01635387
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01635387. Randomized; triple masking; primary purpose treatment. Start 2010-02 (registry gives no type); primary completion 2012-09 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
RAAS Inhibitor Drugs in Dialysis Patients
Condition
Hypertension
Condition
End Stage Renal Disease
Intervention (Drug)
aliskiren
Lead sponsor
University of Campania Luigi Vanvitelli (class: other)
Collaborator
IRCCS San Raffaele (class: other)

Record details

Record id
cardio:ct-nct01635387
Content hash
9ec8ace934fbc7dbd9a9c92397785dff3a616cad2e8033c6bbae1b6bc634b942